Related Experiment Video
Updated: Oct 10, 2025
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
6.6K
How do we optimally utilize factor concentrates in persons with hemophilia?
1Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT.
Hematology. American Society of Hematology. Education Program
|December 10, 2021
Summary
Individualized prophylaxis factor replacement therapy is crucial for hemophilia patients. Tailoring treatment optimizes musculoskeletal health and quality of life by considering patient-specific factors.
Area of Science:
- Hematology
- Pharmacology
Background:
- Hemophilia treatment relies on replacing deficient clotting factors via intravenous administration of factor concentrates.
- Prophylaxis factor replacement therapy is the standard of care for severe hemophilia, aiming to preserve musculoskeletal health and enhance quality of life.
Observation:
- Bleeding presentations in hemophilia are heterogeneous, influenced by genetic, environmental, and treatment factors.
- The World Federation of Hemophilia advocates for individualized prophylaxis regimens to address varying patient needs over time.
Findings:
- This review details practical aspects of selecting factor concentrates, determining optimal dosage and intervals.
- It emphasizes evaluating target trough factor levels and bleeding triggers like physical activity and joint status.
- Pharmacokinetics assessment is discussed as a tool for a tailored, individualized management approach.
Implications:
- Individualized prophylaxis ensures optimal utilization of factor concentrates, maximizing efficacy.
- Personalized treatment plans minimize waste and improve patient outcomes in hemophilia management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.0K
01:29Venous Thrombosis III: Interprofessional Care
52
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
52
01:24Factors Affecting Erythropoiesis
3.8K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.8K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.4K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K
01:28Role of Hematopoietic Growth Factors
1.8K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.8K
01:13Stress Concentrations
357
The concept of stress concentration is crucial for understanding how materials respond under bending stresses, particularly when there are irregularities or discontinuities in the material's geometry. Normally, stress in a symmetric member subjected to pure bending is assumed to be uniformly distributed across the entire cross-section. However, this assumption does not hold when there are variations in the cross-sectional geometry or the presence of notches and holes.
The stress...
The stress...
357